Cargando…
Direct nose to brain delivery of small molecules: critical analysis of data from a standardized in vivo screening model in rats
The blood–brain barrier (BBB) is often a limiting factor for getting drugs in the brain. Bypassing the BBB by intranasal (IN), or also called nose to brain (NTB), route is an interesting and frequently investigated concept for brain drug delivery. However, despite the body of evidence for IN drug de...
Autores principales: | Dhuyvetter, Deborah, Tekle, Fetene, Nazarov, Maxim, Vreeken, Rob J., Borghys, Herman, Rombouts, Frederik, Lenaerts, Ilse, Bottelbergs, Astrid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655051/ https://www.ncbi.nlm.nih.gov/pubmed/33169635 http://dx.doi.org/10.1080/10717544.2020.1837291 |
Ejemplares similares
-
Young to Middle-Aged Dogs with High Amyloid-β Levels in Cerebrospinal Fluid are Impaired on Learning in Standard Cognition tests
por: Borghys, Herman, et al.
Publicado: (2017) -
Nose-to-Brain Delivery
por: Giunchedi, Paolo, et al.
Publicado: (2020) -
BACE1 Inhibition Induces a Specific Cerebrospinal Fluid β-Amyloid Pattern That Identifies Drug Effects in the Central Nervous System
por: Mattsson, Niklas, et al.
Publicado: (2012) -
Ion-Triggered In Situ Gelling Nanoemulgel as a Platform for Nose-to-Brain Delivery of Small Lipophilic Molecules
por: Nagaraja, Sreeharsha, et al.
Publicado: (2021) -
Nanoemulsions for “Nose-to-Brain” Drug Delivery
por: Bonferoni, Maria Cristina, et al.
Publicado: (2019)